We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NVO Novo Nordisk

-0.84 (-0.82%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 4,567,523
Bid Price
Ask Price
News -
Day High 101.76


52 Week Range


Day Low 100.31
Share Name Share Symbol Market Stock Type
Novo Nordisk NVO NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
-0.84 -0.82% 101.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
100.98 100.31 101.76 100.40 101.84
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
55,023 4,567,523 US$ 101.17 US$ 462,084,883 - 62.41 - 105.69
Last Trade Type Quantity Price Currency
18:58:29 7 US$ 100.70 USD

Novo Nordisk (NVO) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Novo Nordisk Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
456.35B 4.50B - 176.95B 55.53B 12.35 8.22
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Novo Nordisk News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NVO Message Board. Create One! See More Posts on NVO Message Board See More Message Board Posts

Historical NVO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week104.30105.69100.31103.083,964,753-3.30-3.16%
1 Month98.74105.6996.00101.114,816,4522.262.29%
3 Months97.075105.6986.9697.744,513,5643.934.04%
6 Months78.83105.6975.5694.392,947,56522.1728.12%
1 Year63.08105.6962.4187.752,185,71037.9260.11%
3 Years33.41105.6933.29567.261,544,29367.59202.3%
5 Years23.10105.6921.8052.111,516,99577.90337.23%

Novo Nordisk Description

Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |